Idéal Investisseur
Français English
CAC 40 :
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35
🏠 Home   ➤    Stock news

EMEIS: EBITDAR Up by 19%, Yet a Net Loss of €298M Continues

EMEIS confirms its exit from the safeguard plan by displaying a sharp operational rebound in 2025: EBITDAR increases by 19.2% on a like-for-like basis, nursing home occupancy improves by 2 points, and resident satisfaction reaches its highest level in three years. Meanwhile, the refinancing of €3.15 billion and asset disposals reduce debt by €1 billion. However, the group records a net loss of €298 million, revealing the ongoing cost of financial restructuring despite an improvement of €114 million year-on-year.


EMEIS: EBITDAR Up by 19%, Yet a Net Loss of €298M Continues

Operational Performance and Revenue Growth

The key indicator of nursing home occupancy rate increased by 2.0 points over twelve months to reach 87.2% at the end of 2025, compared to 85.2% at the end of 2024. This positive momentum supports an organic revenue growth of 6.1%, fueled by a tariff increase of 3.3% and contributions from new facilities. EBITDAR recorded a rise of 19.2% on a like-for-like basis, thus exceeding the provided guidance (between +15% and +18%). This outperformance is driven by all business sectors and regions, particularly France (+15%) and Germany. The EBITDAR margin widened by 1.7 points to 14.8% of revenues, reaching 15.8% in the second half of the year. Operating income (EBIT) increased by €171 million to €173 million, compared to €2 million the previous year.

Non-Financial Indicators and Resident Satisfaction

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

Non-financial indicators reflect a sustainable restoration of trust. The resident satisfaction rate stood at 93.4% at the end of 2025, up by 40 basis points year-on-year and more than 300 points since 2022. The Net Promoter Score (NPS) of residents jumped to 41, from 18 at the end of 2022. These improvements are accompanied by a decrease in the rates of bedsores (1.9% versus 2.2%) and physical restraints (11.2% versus 13.1%). Concurrently, non-recurring expenses increased by €85 million, fueled by the closures of certain facilities in France, Belgium, and Germany, as well as by refinancing costs and the creation of Isemia company. As a result, the net loss improved by €114 million to -€298 million, but remains significantly negative.

Refinancing and Debt Reduction

EMEIS finalizes a refinancing of €3.15 billion with an average maturity of 5.5 years, allowing the full repayment of its previous bank debt. Asset disposals and the Isemia real estate partnership generated €2.35 billion since mid-2022, significantly exceeding the initial target of €1.5 billion. Net debt (excluding IFRS 16, 5, and 9) decreased by €1 billion to reach €3.78 billion on an Isemia proforma basis. The leverage ratio (net debt / EBITDA) improved markedly to 9.9x (proforma) from 19.5x at the end of 2024. For 2026, the group anticipates an EBITDAR growth exceeding 10% on a like-for-like basis and confirms its target of average annual growth between +12% and +16% over 2024-2028. The capital structure has gained strength, with an average debt cost of 4.9% and an average maturity of 5.1 years.



Sector Santé · Etablissements de santé / EHPAD Etablissements de santé


Assurance vie

Context

Period
  • Period: 9M 2025
Guidance from the release
  • Croissance organique soutenue (+6,4% à fin septembre 2025, +7,0% au T3), amélioration notable des taux d'occupation, objectifs de cessions dépassés (2,1 Md€) et confirmation des perspectives 2025 et de la trajectoire 2024-2028.
Risks mentioned
  • Risques et incertitudes liés aux conditions de marché futures pouvant affecter les résultats prévisionnels
  • Risque de non-réalisation ou de délai des cessions actuellement sécurisées ou en négociation
  • Impact transitoire des ouvertures récentes sur les taux d'occupation dans certaines zones
Opportunities identified
  • Croissance démographique des plus de 75 ans (+30% d'ici 10 ans) créant une demande structurelle accrue
  • Déficit structurel d'offre (déficit attendu de lits sur principaux marchés) offrant une forte visibilité commerciale
  • Possibilités de capture d'effets prix favorables et d'amélioration de marges opérationnelles

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit